In 2023, the measles immunisation rate in the US stood at X%, and the forecast for 2024 is at 91%. The forecasted data from 2024 to 2028 show a consistent rate of approximately 90.9%, indicating stability but not growth in immunisation uptake. Year-on-year variations suggest a negligible decline of approximately 0.1% starting in 2025. Over a five-year span, the compounded annual growth rate reflects consistency with no significant upward or downward trend.
Future trends to watch for include potential impacts from changes in healthcare policies, public health campaigns, the influence of vaccine misinformation, and demographic shifts. Attention should also be given to the potential for new vaccine developments or changes in CDC recommendations that could influence immunisation rates moving forward.
